MDLinxRevolutionizing Breast Cancer Screening: Biosensor Detects Cancer with Spit Tests

Salivary Biomarkers Could Open a New Frontier in Breast Cancer Screening

In a recent study, researchers have developed a handheld device that leverages salivary biomarkers to detect breast cancer, offering a potentially transformative approach to early diagnosis and screening. This innovation could significantly streamline the process, making breast cancer detection more accessible and cost-effective, particularly in resource-limited settings.

Key Points:

• Researchers have introduced a handheld device that can detect breast cancer using biomarkers in saliva, presenting a novel non-invasive screening method.
• The device distinguishes between healthy tissue, early-stage, and advanced breast cancer by detecting biomarkers like HER2 and CA 15-3 in saliva.
• During testing with 21 women, the device demonstrated the ability to differentiate between various breast cancer stages swiftly and accurately.
• This cost-effective device, estimated at $5 per unit with inexpensive test strips, delivers results in under five seconds, offering substantial savings in time and cost compared to traditional screening methods.
• The absence of radiation exposure and the need for specialized technology make this device an appealing option, especially in developing countries with limited screening access.
• Historical context highlights ongoing research into saliva’s potential for cancer detection, dating back to the 1950s, and its recent applications in identifying other cancer types.
• Breast cancer screenings have significantly reduced mortality rates; however, disparities in access and technology persist, emphasizing the need for innovative solutions like this device.
• The team aims for further testing to enhance the device’s accuracy and is seeking partnerships for manufacturing and distribution.

“Ultimately, we’ve created a technique that has the potential to help people all around the world. We are excited about the potential to make a significant impact in areas where people might not have had the resources for breast cancer screening tests before.”
– Hsiao-Hsuan Wan, Lead Researcher, Department of Chemical Engineering at the University of Florida

More on Biomarkers